Zev Asch was interviewed by Adam Torres at Mission Matters Business Podcast.
Zev Asch Speaks About Disruptive Thinking for Small Business Owners
January 11, 2022 06:25 ET | Mission Matters Business Podcast
Beverly Hills , Jan. 11, 2022 (GLOBE NEWSWIRE) -- Zev Asch's mission and purpose are one and the same: to change the lives of business owners by helping them grow their companies and achieve a...
Qualigen-Logo-Tag.png
Qualigen Therapeutics Promotes Amy Broidrick to President
December 14, 2021 09:18 ET | Qualigen Therapeutics, Inc.
Ms. Broidrick to retain title of Chief Strategy Officer CARLSBAD, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on...
Aptive x Inc. Best in Business Image
Aptive Environmental Recognized On Inc.’s 2021 Best in Business List
December 07, 2021 13:46 ET | Aptive Environmental
PROVO, Utah, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Aptive Environmental, one of the fastest-growing pest control companies in North America, has been recognized on the Inc. 2021 Best in Business list as...
Qualigen-Logo-Tag.png
Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
December 01, 2021 15:25 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with certain...
Qualigen-Logo-Tag.png
QUALIGEN THERAPEUTICS, INC. ANNOUNCES $8.82 MILLION COMMON STOCK REGISTERED DIRECT OFFERING
November 29, 2021 15:50 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of cancer,...
Qualigen-Logo-Tag.png
Qualigen Therapeutics, Inc. Reports Third Quarter 2021 Financial Results
November 15, 2021 09:00 ET | Qualigen Therapeutics, Inc.
Quarterly revenues increased 38% to approximately $1.2 million, compared to approximately $0.8 million in the same quarter of the previous yearYear-to-date revenues increased 30% to $4.2 million,...
Access_Logo_RGB_Full_Color_092419.jpg
For the 12th Time, Access Recognized on the Inc. 5000, With Three-Year Revenue Growth of 43 Percent
November 03, 2021 12:15 ET | Access
WOBURN, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, today announced that it is being recognized for the...
Qualigen-Logo-Tag.png
Peer-Reviewed Article Confirms That Qualigen’s FastPack® is as Accurate in Thyroid Stimulating Hormone Measurement -- and Much Faster -- Than a Leading Laboratory Method
October 19, 2021 09:00 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with...
Qualigen-Logo-Tag.png
Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 15, 2021 07:30 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with...
DKBinnovative logo
DKBinnovative Named to the Prestigious Inc. 5000 List for the 5th Consecutive Year
September 09, 2021 05:00 ET | DKBinnovative
FRISCO, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Inc. magazine has ranked DKBinnovative as No. 2,397 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing...